Showing results (101-110 of 183) with videos related to
Sort By:
Pageof 19
Journal of Cardiovascular Pharmacology|February 24, 2006
Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertensionHideki Fujio, Kazufumi Nakamura, Hiromi Matsubara, et al.JACC. Asia|April 11, 2026
Association Between Current of Injury Magnitude and Intraoperative R-Wave Amplitude Fluctuation After Pacing Lead ImplantationYoshitake Oshima, Satoshi Oka, Kohei Ishibashi, et al.Heart and Vessels|October 22, 2021
Impact of nocturnal hypoxemia on the recurrence of atrial tachyarrhythmia after catheter ablation of atrial fibrillationKeisuke Suzuki, Koji Miyamoto, Akinori Wakamiya, et al.International Heart Journal|July 19, 2021
Pulmonary Vein Isolation and Pacemaker Implantation in a Patient with Dextrocardia Situs InversusYasuhiro Yokoyama, Takeshi Aiba, Koji Miyamoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|May 1, 2004
Sinus node function in patients with Brugada-type ECGHiroshi Morita, Kengo Fukushima-Kusano, Satoshi Nagase, et al.Journal of Arrhythmia|October 13, 2017
Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemiaRyota Kitajima, Takeshi Aiba, Tsukasa Kamakura, et al.Journal of the American College of Cardiology|November 11, 2003
Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndromeHiroshi Morita, Shiho Takenaka Morita, Satoshi Nagase, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|September 21, 2025
Clinical Implications of Non-Sustained Ventricular Tachycardia in the Indication for Primary Prevention With an Implantable Cardioverter Defibrillator - Subanalysis From the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE)Kohei Ishibashi, Satoshi Oka, Toshihiro Nakamura, et al.Journal of Cardiology Cases|November 2, 2020
Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5AYasuhiro Yokoyama, Takeshi Aiba, Nobuhiko Ueda, et al.Journal of Cardiovascular Pharmacology|July 14, 2010
Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutationMasato Murakami, Kazufumi Nakamura, Kengo F Kusano, et al.Pageof 19